Regulation of Bim in glucocorticoid-mediated osteoblast apoptosis

Journal of Cellular Physiology

Volumn 215, Issue 2, 2008, Pages 488-496

  Espina, B ^a   Liang, M ^a   Russell, R G G ^a   Hulley, P A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BIM PROTEIN; CYCLOHEXIMIDE; DEXAMETHASONE; GLUCOCORTICOID; MESSENGER RNA; MIFEPRISTONE; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA; APOPTOSIS REGULATORY PROTEIN; BCL 2 LIKE PROTEIN 11; BCL-2-LIKE PROTEIN 11; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CYSTEINE PROTEINASE INHIBITOR; GLUCOCORTICOID RECEPTOR; LEUPEPTIN; MEMBRANE PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BONE MARROW; CONCENTRATION RESPONSE; GENE SILENCING; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN SYNTHESIS REGULATION; STROMA CELL; TRANSCRIPTION REGULATION; UPREGULATION; BONE MARROW CELL; CELL CULTURE; CULTURE MEDIUM; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; EXTRACELLULAR MATRIX; GENETICS; METABOLISM; PHYSIOLOGY; TIME;

MURINAE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BONE MARROW CELLS; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; CYCLOHEXIMIDE; CYSTEINE PROTEINASE INHIBITORS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; GLUCOCORTICOIDS; HUMANS; LEUPEPTINS; MEMBRANE PROTEINS; MIFEPRISTONE; OSTEOBLASTS; PROTO-ONCOGENE PROTEINS; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; RNA, SMALL INTERFERING; STROMAL CELLS; TIME FACTORS; UP-REGULATION;

EID: 40949152998     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21335     Document Type: Article

References (47)

1. Abrams MT, Robertson NM, Yoon K, Wickstrom E. 2004. Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA. J Biol Chem 279:55809-55817.
2. Abu EO, Horner A, Kusec V, Triffitt JT, Compston JE. 2000. The localization of the functional glucocorticoid receptor alpha in human bone. J Clin Endocrinol Metab 85:883-889.
3. Ahuja SS, Zhao S, Bellido T, Plotkin LI, Jimenez F, Bonewald LF. 2003. CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology 144:1761-1769.
4. Akiyama T, Bouillet P, Miyazaki T, Kadono Y, Chikuda H, Chung UI, Fukuda A, Hikita A, Seto H, Okada T, Inaba T, Sanjay A, Baron R, Kawaguchi H, Oda H, Nakamura K, Strasser A, Tanaka S. 2003. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J 22:6653-6664.
5. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, Adams JM, Strasser A. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735-1738.
6. Caron-Leslie LA, Evans RB, Cidlowski JA. 1994. Bcl-2 inhibits glucocorticoid-induced apoptosis but only partially blocks calcium ionophore or cycloheximide-regulated apoptosis in S49 cells. FASEB J 8:639-645.
7. Chua C, Chua B, Chen Z, Landy C, Hamdy R. 2003. Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells. Biochim Biophys Acta 1642:79-85.
8. Cifone MG, Migliorati G, Parroni R, Marchetti C, Millimaggi D, Santoni A, Riccardi C. 1999. Dexamethasone-induced thymocyte apoptosis: Apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 93:2282-2296.
9. De Bosscher K, Vanden Berghe W, Haegeman G. 2003. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: Molecular mechanisms for gene repression. Endocr Rev 24:488-522.
10. De Wet H, Conradie M, Langeveldt CR, Hulley PA. 2003. The identification of trancriptional targets associated with GC-induced apoptosis and survival in human and mouse osteoblast cell lines. Eur J Biochem 270:PS01-0318.
11. Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ. 2000. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 10:1201-1204.
12. Donovan M, Cotter TG. 2004. Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. Biochim Biophys Acta 1644:133-147.
13. Eberhardt AW, Yeager-Jones A, Blair HC. 2001. Regional trabecular bone matrix degeneration and osteocyte death in femora of glucocorticoid-treated rabbits. Endocrinology 142:1333-1340.
14. Erlacher M, Michalak EM, Kelly PN, Labi V, Niederegger H, Coultas L, Adams JM, Strasser A, Villunger A. 2005. BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation-and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 106:4131-4138.
15. Espina B, Conradie R, Russell G, Hulley PA. 2005. The BH3-only protein Bim is upregulated in osteoblasts in response to dexamethasone treatment, growth factor deprivation and anoikis. Bone 36:S103-S479.
16. Essafi A, Fernandez de Mattos S, Hassen YA, Soeiro I, Mufti GJ, Thomas NS, Medema RH, Lam EW. 2005. Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 24:2317-2329.
17. Fried A, Benayahu D, Wientroub S. 1993. Marrow stroma-derived osteogenic clonal cell lines: Putative stages in osteoblastic differentiation. J Cell Physiol 155:472-482.
18. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Borstein M, O'shea JJ, Chrousos GP, Bornstein SR. 2002. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on inmune cells. FASEB J 16:61-71.
19. Gohel A, McCarthy MB, Gronowicz G. 1999. Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 140:5339-5347.
20. Gorczyca W, Melamed MR, Darzynkiewicz Z. 1993. Apoptosis of S-phase HL-60 cells induced by DNA topoisomerase inhibitors: Detection of DNA strand breaks by flow cytometry using the in situ nick translation assay. Toxicol Lett 67:249-258.
21. Gu G, Hentunen TA, Nars M, Harkonen PL, Vaananen HK. 2005. Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis. Apoptosis 10:583-595.
22. Han J, Flemington C, Houghton AB, Gu Z, Zambetti GP, Lutz RJ, Zhu L, Chittenden T. 2001. Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci USA 98:11318-11323.
23. Hulley PA, Gordon F, Hough FS. 1998. Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 15.4) by dexamethasone: Role of protein phosphatases. Endocrinology 139:2423-2431.
24. Jesenberger V, Jentsch S. 2002. Deadly encounter: Ubiquitin meets apoptosis. Nat Rev Mol Cell Biol 3:112-121.
25. Katychev A, Wang X, Duffy A, Dore-Duffy P. 2003. Glucocorticoid-induced apoptosis in CNS microvascular pericytes. Dev Neurosci 25:436-446.
26. Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH. 2006. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8:1348-1358.
27. Kogianni G, Mann V, Ebetino F, Nuttall M, Nijweide P, Simpson H, Noble B. 2004. Fas/CD95 is associated with Glucocortioid-induced osteocyte apoptosis. Life Sci 75:2879-2895.
28. Ley R, Balmanno K, Hadfield K, Weston C, Cook SJ. 2003. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J Biol Chem 278:18811-18816.
29. Li B, Dou QP. 2000. Bax degradation by the ubiquitin/proteasome-dependent pathway: Involvement in tumor survival and progression. Proc Natl Acad Sci USA 97:3850-3855.
30. Liang M, Espina B, Russell G, Hulley P. 2007. Bim is transcriptionally regulated during induction of apoptosis by growth factor withdrawal in osteoblasts. Calcif Tissue Int 80:s81.
31. Luciano F, Jacquel A, Colosetti P, Herrant M, Cagnol S, Pages G, Auberger P. 2003. Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function, Oncogene 22:6785-6793.
32. Marani M, Hancock D, Lopes R, Tenev T, Downward J, Lemoine NR. 2004. Role of Bim in the survival pathway induced by Raf in epithelial cells. Oncogene 23:2431-2441.
33. Marchetti MC, Di Marco B, Cifone G, Migliorati G, Riccardi C. 2003. Dexamethasone-induced apoptosis of thymocytes: Role of glucocorticoid receptor-associated Src kinase and caspase-8 activation. Blood 101:585-593.
34. Memon SA, Moreno MB, Petrak D, Zacharchuk CM. 1995. Bcl-2 blocks glucocorticoid-but not Fas- or activation-induced apoptosis in a T cell hybridoma. J Immunol 155:4644-4652.
35. O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S, Huang DC. 1998. Bim: A novel member of the Bcl-2 family that promotes apoptosis. EMBO J 17:384-395.
36. Planey SL, Derfoul A, Steplewski A, Robertson NM, Litwack G. 2002. Inhibition of glucocorticoid-induced apoptosis in 697 pre-B lymphocytes by the mineralocorticoid receptor N-terminal domain. J Biol Chem 277:42188-42196.
37. Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T, 1999. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363-1374.
38. Puthalakath H, Huang DC, O'Reilly LA, King SM, Strasser A. 1999. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 3:287-296.
39. Reginato MJ, Mills KR, Paulus JK, Lynch DK, Sgroi DC, Debnath J, Muthuswamy SK, Brugge JS. 2003. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 5:733-740.
40. Schacke H, Docke WD, Asadullah K. 2002. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96:23-43.
41. Strasser A, Puthalakath H, Bouillet P, Huang DC, O'Connor L, O'Reilly LA, Cullen L, Cory S, Adams JM. 2000. The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control. Ann N Y Acad Sci 917:541-548.
42. Suzuki Y, Nakabayashi Y, Takahashi R. 2001. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci USA 98:8662-8667.
43. Wang Z, Malone MH, He H, McColl KS, Distelhorst CW. 2003. Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J Biol Chem 278:23861-23867.
44. Warton K, Foster NC, Gold WA, Stanley KK. 2004. A novel gene family induced by acute inflammation in endothelial cells. Gene 342:85-95.
45. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. 1998. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274-282.
46. Yamamoto T, Nishiguchi M, Inoue N, Goto HG, Kudawara I, Ueda T, Yoshikawa H, Tanigaki Y, Nishizawa Y. 2002. Inhibition of murine osteosarcoma cell proliferation by glucocorticoid. Anticancer Res 22:4151-4156.
47. Zalavras C, Shah S, Birnbaum M, Frenkel B. 2003. Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis. Crit Rev Eukaryot Gene Expr 13:221-235.